Latest Product Pipeline News

Page 11 of 16
Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.
Ada Torres
Ada Torres
26 Aug 2025
Codan Limited reported a robust FY25 with revenue climbing 22% to $674.2 million and net profit rising 27%, driven by strong performances in its Communications and Metal Detection segments.
Sophie Babbage
Sophie Babbage
21 Aug 2025
Codan Limited has delivered a robust FY25 performance, with revenue up 22% and net profit rising 27%, underpinned by strong growth in its Communications and Metal Detection segments. The company also announced a 27% increase in dividends and a significant reduction in net debt.
Sophie Babbage
Sophie Babbage
21 Aug 2025
Pepper Money Limited reported a solid half-year performance with a 2% rise in net profit after tax and record assets under management of $20.1 billion. The company declared a 6.4 cent interim dividend, reflecting disciplined cost control and a positive outlook.
Claire Turing
Claire Turing
21 Aug 2025
Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.
Ada Torres
Ada Torres
18 Aug 2025
Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.
Ada Torres
Ada Torres
13 Aug 2025
Universal Biosensors updates investors on a shift from a secured loan to a potential entitlement offer, signaling evolving funding strategies and extended timelines.
Ada Torres
Ada Torres
7 Aug 2025
Universal Biosensors reported a 44% increase in net loss to A$10.45 million for H1 2025, alongside an 11% revenue decline, raising serious going concern doubts. The company is pursuing an A$8.5 million senior secured loan and equity raise to sustain operations.
Ada Torres
Ada Torres
4 Aug 2025
Swift Networks reports positive FY25 cash flow and EBITDA, secures new mining contracts, and progresses its next-generation Swift Access 2026 platform poised to accelerate growth.
Sophie Babbage
Sophie Babbage
31 July 2025
Auric Mining wraps up its final gold processing campaign at Jeffreys Find with strong cash flow, while advancing mining and acquisitions at Munda and Higginsville to fuel growth.
Maxwell Dee
Maxwell Dee
31 July 2025
Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.
Maxwell Dee
Maxwell Dee
31 July 2025
EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.
Victor Sage
Victor Sage
29 July 2025

Browse the archive

Full archive